Search Results

In GPCR drug discovery, a single mistaken assumption can derail an entire program. Terry Kenakin reframes one of pharmacology’s most foundational ideas: the difference between competitive Inside the Lesson: Antagonist Behavior by the Numbers Terry walks through both the pharmacologic and If you want to avoid costly misinterpretations and strengthen your pharmacology toolkit, Terry’s Corner Brief today  ➤   #GPCRantagonism #CompetitiveAntagonists #NonCompetitiveAntagonists #DoseResponseCurve #Pharmacology

Teams equipped with deep GPCR pharmacology insights make different decisions. The sections below synthesize the key topics addressed during the AMA and highlight the GPCR pharmacology This is a core GPCR pharmacology insight:ligand → receptor → G protein is never the entire story. These are core GPCR pharmacology insights for preventing interpretive drift as programs move toward in GPCR innovation is accelerating, and those who invest in deeper GPCR pharmacology insights today will

2026 GPCR Pharmacology AMA: Receptor Theory, Biased Signaling & Assay Interpretation The first GPCR Pharmacology The objective is straightforward: Make mechanistic pharmacology easier to access, revisit, and apply Biased Signaling Terry Kenakin, Ph.D., Professor of Pharmacology at the University of North Carolina Access the white paper here Why Terry’s Pharmacology Corner Mechanistic understanding evolves. Forty years of pharmacological expertise — organized into a year-round framework for serious GPCR scientists

Equip your research team with expert-led GPCR pharmacology training. Shared depth in GPCR pharmacology—built for scientific teams One team membership. Shared pharmacology expertise. Faster, better decisions. Access monthly courses, live AMAs, and hard-won insight from 40+ years shaping GPCR pharmacology. Expert-Level Mastery — Advanced Pharmacology Live AMA Sessions with Terry

, pharmacology, signaling, and drug discovery. Who should attend these GPCR pharmacology webinars? GPCR platform. Do I need prior knowledge of GPCR pharmacology? These webinars are designed to support ongoing scientific development in GPCR pharmacology and drug discovery on receptor pharmacology and drug discovery.

through empowerment and purpose. << Back to podcast list Strategic Partner(s) GPCR Pharmacology, Career Starting at DuPont, then BMS, Novartis, and eventually founding in vitro pharmacology departments, Sokhom Falling in Love with GPCRs GPCR pharmacology captured his scientific curiosity. Sokhom recalls how binding assays at BMS introduced him to the depth and complexity of receptor pharmacology He blends classical receptor pharmacology with biosensor technology, always adapting to new tools and